Vericiguat is a novel investigational drug developed by Merck & Co. Inc. It is a soluble guanylate cyclase (sGC) stimulator, which is being investigated as a potential treatment for chronic heart failure (CHF). It works by increasing the production of a gas called nitric oxide (NO) within the body, which helps to improve heart function and reduce the risk of heart failure-related hospitalizations. In clinical trials, Vericiguat has been shown to improve exercise capacity and quality of life in patients with CHF. It is currently in Phase III clinical trials and is not yet approved for use in the US.
Vericiguat is a medication used specifically to manage chronic heart failure with a weakened pumping ability, medically termed heart failure with reduced ejection fraction (HFrEF). It works by improving blood flow and reducing strain on the heart. Here's a closer look at Vericiguat:
- Function: Vericiguat belongs to a drug class called soluble guanylate cyclase (sGC) stimulators. It works by increasing the production of a molecule called cyclic guanosine monophosphate (cGMP) within heart and blood vessel cells. cGMP helps relax blood vessels, allowing blood to flow more easily throughout the body and reducing the workload on the heart.
- Use: Vericiguat is prescribed to adults with chronic HFrEF to:
- Reduce the risk of death from heart failure complications.
- Lower the chances of needing hospitalization due to worsening heart failure.
- Dosage and Administration: Vericiguat comes as tablets taken by mouth, usually once daily with food. The exact dosage is determined by your doctor based on your individual health condition and response to the medication.
- Important Safety Information:
- Vericiguat can cause low blood pressure, especially when taken with other medications that also lower blood pressure.
- It may not be suitable for people with certain underlying health conditions or those taking specific medications.
- Vericiguat can interact with other medications, so it's crucial to disclose all your medications to your doctor before starting it.
- Pregnant women should strictly avoid Vericiguat due to potential harm to the developing fetus.